Official SEC submissions

NervGen Pharma SEC Filings

Direct answer

NervGen Pharma's latest SEC filing is 6-K.

It was filed on August 13, 2026, and 12 recent filings are available.

Each row links directly to the SEC document and filing index.

Official SEC EDGAR submissions

Get free NervGen Pharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

6-K

Current report

Filed: 2026-08-13

Report date: 2026-08-13

FORM 6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-07-02

Report date: 2026-07-02

FORM 6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-06-01

Report date: 2026-06-01

FORM 6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-05-26

Report date: 2026-05-26

FORM 6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-05-22

Report date: 2026-05-22

FORM 6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-05-18

Report date: 2026-05-18

FORM 6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-05-15

Report date: 2026-05-15

FORM 6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-04-27

Report date: 2026-04-27

FORM 6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-03-13

Report date: 2026-03-13

FORM 6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-02-13

Report date: 2026-02-13

FORM 6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-02-10

Report date: 2026-02-10

FORM 6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-01-08

Report date: 2026-01-08

FORM 6-K

Open SEC document View filing index

Verified data

Recent filing categories: 1
Recent filings: 12
SEC CIK: 0001751912
Latest filing date: August 13, 2026

Explore related company data

View the NervGen Pharma company profile View NervGen Pharma annual financials